Classifications

• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
  • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
  • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
  • A61K8/9783—Angiosperms [Magnoliophyta]
  • A61K8/9789—Magnoliopsida [dicotyledons]
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
  • A61K36/18—Magnoliophyta (angiosperms)
  • A61K36/185—Magnoliopsida (dicotyledons)
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
  • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
  • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
  • A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
  • A61Q19/00—Preparations for care of the skin
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
  • A61Q19/00—Preparations for care of the skin
  • A61Q19/08—Anti-ageing preparations
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
  • A61Q5/00—Preparations for care of the hair
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
  • A61Q5/00—Preparations for care of the hair
  • A61Q5/002—Preparations for repairing the hair, e.g. hair cure
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
  • A61Q5/00—Preparations for care of the hair
  • A61Q5/02—Preparations for cleaning the hair
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
  • A61Q5/00—Preparations for care of the hair
  • A61Q5/12—Preparations containing hair conditioners
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
  • A61Q7/00—Preparations for affecting hair growth
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
  • A61K2236/10—Preparation or pretreatment of starting material
  • A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
  • A61K2236/30—Extraction of the material
  • A61K2236/37—Extraction at elevated pressure or temperature, e.g. pressurized solvent extraction [PSE], supercritical carbon dioxide extraction or subcritical water extraction
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
  • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
  • A61K2800/805—Corresponding aspects not provided for by any of codes A61K2800/81 - A61K2800/95

Definitions

• the invention relates to new cosmetic uses of a cake hydrolyzate of Hippophae rhamnoides.
• the care of skin appendages such as hair, eyelashes, eyebrows, involves a global treatment, i.e. a direct treatment of the hair fiber or keratin fiber but also of the corresponding skin area, including the hair follicles .
• a global treatment i.e. a direct treatment of the hair fiber or keratin fiber but also of the corresponding skin area, including the hair follicles .
• these hair follicles are spread all over the scalp and are responsible for hair growth.
• These follicles indeed include cells of proliferative epithelial origin in the lower part of the follicle, at the level of the bulb.
• the direct care of the hair fiber involves the treatment of the proteins that constitute it. Keratins, for example, are particularly sensitive to damage induced by an urban lifestyle, the frequency of use of hygiene chemicals, styling habits, but also environmental conditions, i.e. sun, pollution , salt, wind, variations in climatic conditions, general lifestyle and age. These proteins will denature and make the skin appendages, in particular the hair, less resistant, less flexible, brittle, but also duller and more split ends. These appendages lose their biomechanical properties and their surface properties.
• Hydrolysis is a necessary process, however, to break down the i proteins, promote their solubility in water and in this case their penetration into the hair fiber, making them usable in cosmetic formulations. Only low molecular weight molecules can penetrate the fiber, especially damaged hair fibers. These hydrolyzed proteins help improve moisture retention, elasticity of hair fibers and provide more softness, shine, bounce and body. They help strengthen the hair fiber from the inside.
• High-performance hydrolyzed proteins have substantivity properties for the hair fiber (weak bonds with hair keratins) due to ionic charges and polar sites (interactions by van der Walls forces). They can also form protective films on the surface of the hair fiber.
• hydrolyzed proteins exist on the cosmetics market. These proteins are of vegetable or animal origin. The most common are hydrolyzed proteins from wheat, silk, keratin, collagen, elastin, milk, almonds. However, there is a constant need for effective alternative ingredients in the field.
• a cake hydrolyzate of H. rhamnoides had the ability to penetrate the keratin fiber, to increase its mechanical properties, as well as its texture and surface properties.
• This hydrolyzate has been shown to be able to increase the growth of cutaneous appendages, fight against their fall, increase their resistance and reduce their breakage, in particular that of the hair, making them shinier, more radiant and with volume.
• the meal hydrolyzate of H. rhamnoides has skin adnexa repair properties as will be demonstrated in the following description.
• An advantage of the hydrolyzate according to the present invention is that it is a product resulting from an industrial extraction residue that is usually not recovered, the development of the product thus being part of an eco-friendly approach. responsible. Yet another advantage is that it is an ingredient providing complete care, since it has effects both on the keratin fibre, in particular the hair, but also on the scalp and the hair follicles. Furthermore, the hydrolyzate according to the invention can easily be produced on an industrial scale. Finally, enzymatic hydrolysis makes it possible to fractionate the proteins of the meal to recover low molecular weight peptides, those precisely which can penetrate the keratin fibers to ensure the cosmetic effects described here.
• the hydrolyzate according to the invention comes from the cake of the Hippophae rhamnoides plant.
• This plant also called sea buckthorn is known for its ancient uses. Thus, in ancient Greece, its leaves were used as food for animals, especially horses to increase the shine of their coat.
• the Greeks also used the berries therapeutically to reduce pain, stomach aches and treat scurvy.
• Leaf extracts have also been used to treat asthma, gastric ulcers, skin problems (scarring, burns) and lungs.
• the fruit of H. rhamnoides is used to relieve coughs and transform phlegm, fortify the stomach and relieve difficult digestions, activate the blood and dissipate stasis.
• Sea Buckthorn In Central Asia, local populations used Sea Buckthorn to treat hypertension, digestive and skin disorders.
• the oil extracted from the berries is used for its anti-inflammatory properties and gastric ulcers.
• the decoction of the dried fruits is used for skin problems.
• Applications CN105063139 and CN108065411 disclose peptide hydrolysates from the supercritical CO 2 extraction residue of the seeds of H. rhamnoides. These are hydrolysates obtained by enzymatic hydrolysis. However, neither of these two applications discloses the cosmetic or dermatological applications forming the subject of the present invention.
• Application CN108354862 describes a composition comprising, among other things, an oil of H. rhamnoides, for an anti-dandruff and soothing effect. However, it is an oil and not a hydrolyzate on the one hand and the cosmetic effects described in the present invention are distinct from the anti-dandruff effect of this application on the other hand.
• Application FR3031455 describes several molecules that can be extracted from H. rhamnoides and intended to be incorporated into a cosmetic composition, in particular as a repairing agent, inter alia for the hair.
• a cosmetic composition in particular as a repairing agent, inter alia for the hair.
• no disclosure or suggestion of the precise effects described in the present invention is mentioned.
• an extract of the plant H. rhamnoides is disclosed without further description of the type of extract.
• Application FR2943255 describes the use of an oil extract of H. rhamnoides obtained by supercritical CO 2 extraction to stimulate the activity of alpha-5-reductase, to improve the loss of shine in the hair.
• the supercritical CO 2 extraction product not its co-product, even less the hydrolyzate of the latter.
• the cosmetic effects described in the present application are neither disclosed nor suggested therein.
• Application WO2009125071 describes several plant extracts obtained from supercritical CO 2 extraction co-products, which co-products are then subjected to hydroalcoholic extraction or with a mixture of water and butylene glycol in particular.
• a fruit extract of H. rhamnoides is discloses.
• the extract of the present invention is distinct since it is a hydrolyzate of the coproduct of H. rhamnoides.
• This application also does not describe at all the cosmetic effects described in the present invention and in particular does not describe any effect on the appendages of the skin.
• a first object thus concerns the non-therapeutic cosmetic use of a hydrolyzate of H. rhamnoides for augmentation to increase the growth of skin appendages and/or decrease their loss, advantageously of hair; and/or to maintain and/or increase the biomechanical properties and/or the surface and/or texture properties of the skin appendages, advantageously of the hair; and/or to repair damaged skin appendages, advantageously the hair.
• a second object relates to the non-therapeutic cosmetic use of the hydrolyzate in a cosmetic composition.
• a third object concerns a non-therapeutic cosmetic care process comprising the topical application of the hydrolyzate according to the invention or of a cosmetic composition comprising it.
• a 4th object relates to a method of cosmetic treatment and a last object relates to the hydrolyzate according to the invention for its dermatological or pharmaceutical use.
• a first object therefore concerns the non-therapeutic cosmetic use of a hydrolyzate of H. rhamnoides to increase the growth of skin appendages and/or reduce their loss, advantageously of hair; and/or to maintain and/or increase the properties biomechanical properties and/or the surface and/or texture properties of the skin appendages, advantageously of the hair; and/or to repair damaged skin appendages, advantageously the hair.
• cosmetic use means a non-therapeutic, non-pharmaceutical or dermatological use, that is to say which does not require therapeutic treatment and intended for healthy skin and/or skin appendages and/or mucous membranes.
• health means skin or cutaneous appendages or mucous membranes qualified as non-pathological by a specialist in the field, a dermatologist, i.e.
• damaged skin appendages are appendages qualified as non-pathological by the specialist in the field.
• damaged skin appendages are appendages which have lost their suppleness and/or their elasticity and/or their ability to deform in particular and which consequently are dehydrated.
• “Damaged” cutaneous appendages lose their structure and/or visual and/or biomechanical properties. Thus, they become dull and rough, are less resistant, become friable, brittle, split and/or curl and are therefore forked. They are also rough and therefore less soft, difficult to comb and shape. This loss of surface quality of the hair is visible and unsightly. The hair also reflects less light and is thus visibly less shiny, less luminous. They are also thinner and thinner.
• skin appendages is understood here to mean the hair, the eyelashes, the eyebrows, the body hair, in particular beard hair, and/or the nails.
• the beard includes the mustache Preferably, it is hair.
• the hydrolyzate according to the invention is a topically acceptable ingredient.
• topically acceptable means an ingredient suitable for a topical application, non-toxic, non-irritating to the skin, in particular the scalp, or the mucous membranes or skin appendages, not inducing an allergic or inflammatory response, which is not chemically unstable.
• the use of the hydrolyzate can be orally or topically.
• it is applied topically.
• topical route means the direct local application and/or the vaporization of the ingredient on the surface of the skin and/or the mucous membranes and/or the skin appendages, in particular the skin appendages.
• the topical route excludes application to the skin, including the scalp and/or the mucous membranes.
• the hydrolyzate can be applied topically to all or part of the skin of the body and/or of the face chosen from among the scalp, legs, thighs, arms, stomach, Vietnameselleté, neck, all or part of the face, the forehead, the chin, the lips, the contour of the lips, the contour of the eyes, the so-called “T” zone of the face, and advantageously the scalp, and/or on all or part of the skin appendages, advantageously on the nails, hair, body hair, in particular beard hair, eyelashes and/or eyebrows, even more advantageously on the hair, more preferentially the hair.
• skin we therefore also mean the scalp.
• One object of the invention thus relates to the non-therapeutic cosmetic use of a /7 meal hydrolyzate. rhamnoides to increase the growth of skin appendages and/or reduce their loss, advantageously of hair; and/or to maintain and/or increase the biomechanical properties and/or the surface and/or texture properties of the skin appendages, advantageously of the hair; and/or to repair damaged skin appendages, advantageously the hair.
• These properties can be evaluated ex-vivo by measuring their resistance to tensile forces.
• These biomechanical parameters, in particular those of the hair, can be evaluated in response to stretching and can be measured for example by the tensile test (Dia-Stron).
• the parameters measured can be elastic modulus (Pa), elongation at break (%), force at break (gmf), gradient of the post-yield plastic region (gmf / % elongation) and are normalized with respect to to the diameter of the skin appendages.
• This last parameter (gradient) allows the measurement of the plasticity of the study material just before the breakage.
• the technique makes it possible to obtain a stress (or force) curve as a function of the characteristic elongation of the material studied.
• "maintaining and/or increasing the biomechanical properties" of the cutaneous appendages means reducing the glycation products (Advanced Glycation End Products or AGEs) which appear during chrono-induced or photo-induced aging in particular, but also which appear on a daily basis in response to environmental conditions, in contact with chemical or physical oxidative agents. These glycation products decrease the biomechanical properties of the appendages.
• glycation products Advanced Glycation End Products or AGEs
• the hydrolyzate according to the invention is in an amount effective for "maintaining and/or increasing the biomechanical properties of the cutaneous appendages" when the percentage of glycation products measured following the oxidation of albumin as a marker protein, in the presence of iron as catalyst and hydrogen peroxide as oxidizing agent, and in the presence of the hydrolyzate according to the invention, is reduced by at least 20%, advantageously by at least 25% and even more advantageously by at least 50%, by relative to the percentage of glycation products detected under the same conditions but without extract.
• the skin appendages are the hair. Again advantageously, this is a reduction in the glycation products detected in the presence of the hydrolyzate as prepared according to example 1a) and under the conditions described in example 3a) (Table 3).
• "maintaining and/or increasing the biomechanical properties" of the cutaneous appendages means reducing the degradation of tryptophan measured in the presence of the hydrolyzate according to the invention following the oxidation of albumin in the presence of hydrogen peroxide and iron as oxidation catalyst, of at least 30%, advantageously of at least 40% and still advantageously of at least 95%, relative to the percentage of degradation of tryptophan measured in the absence of the hydrolyzate according to the invention.
• the skin appendages are the hair. Again advantageously, it is the hydrolyzate as prepared according to Example 1 a), under the conditions described in Example 3b) (Table 4).
• “maintaining and/or increasing the biomechanical properties of the cutaneous appendages” means decreasing the formation of dityrosine detected in the presence of iron and hydrogen peroxide after oxidation of albumin, d at least 35%, preferably at least 55%, in the presence of the hydrolyzate according to the invention.
• the skin appendages are the hair.
• the hydrolyzate is the hydrolyzate as prepared according to Example 1 a), under the conditions described in Example 3c) (Table 5).
• “maintaining and/or increasing the biomechanical properties of the skin appendages” means decreasing the formation of pentosidine detected in the presence of iron after oxidation of albumin in the presence of hydrogen peroxide , of at least 35%, preferably of at least 60%, in the presence of the hydrolyzate according to the invention.
• the skin appendages are the hair.
• the hydrolyzate is the hydrolyzate as prepared according to Example 1 a), under the conditions described in Example 3d) (Table 6).
• “maintaining and/or increasing the biomechanical properties of the cutaneous appendages” means reducing the formation of Schiff's bases, glycation intermediate products, in the presence of copper and lipoproteins, of at least 11%, advantageously at least 18%, very advantageously at least 93% in the presence of the hydrolyzate according to the invention, versus the quantity of said Schiff bases measured under the same conditions without hydrolyzate.
• the skin appendages are the hair.
• the hydrolyzate is the hydrolyzate as prepared according to Example 1 a), under the conditions described in Example 3d) (Table 7).
• the hydrolyzate according to the invention is therefore effective and can be used to increase the resistance, the elasticity, the flexibility, the strength and/or the plasticity of the skin appendages, and preferentially those of the hair, and is thus capable of reducing their broken.
• the term “maintaining and/or increasing the surface and/or texture properties” of the skin appendages, advantageously the hair, is also understood to mean making said skin appendages smoother and/or softer and/or less rough and therefore visually more shiny and /or more luminous and thus easy to detangle and/or easy to style and/or easy to shape.
• These properties can be evaluated by technique imaging, for example by video-microscopy or electron microscopy, or by sensory tests on locks of hair, carried out by external volunteers trained to define their visual or tactile sensations or even by evaluation tests by experts (hairdressers ) or self-assessment through consumer questionnaires.
• the effectiveness of a product in its formula is evaluated according to visual or tactile quality criteria perceptible to the hair.
• the term “maintaining and/or increasing the growth of the cutaneous appendages” also means maintaining and/or increasing the amount of DNA in the fibroblasts of the papilla of the hair follicles. In one embodiment, this is an increase in the quantity of DNA of at least 20%, advantageously of at least 30% and even more advantageously of at least 40%, measured in the fibroblasts of the hair papilla in the presence of the hydrolyzate according to the invention in comparison with the amount of DNA measured in the absence of the hydrolyzate on unsensitized fibroblasts.
• the hydrolyzate according to the invention is that described in Example 1a), under the measurement conditions as set out in Example 4 (Table 8).
• "maintaining and/or increasing the growth of skin appendages” means increasing the amount of ATP in the fibroblasts of the papilla of the hair follicles. In one embodiment, it is an increase in the quantity of ATP measured at the level of the fibroblasts of the hair papilla in the presence of the hydrolyzate according to the invention, of at least 10%, preferentially of at least 15% and even more preferably at least 40%, in comparison with the quantity of ATP measured without hydrolyzate.
• the hydrolyzate according to the invention is that described in Example 1 a), under the measurement conditions as set out in Example 4 (Table 9).
• "maintaining and/or increasing growth of skin appendages” means it maintaining and/or increasing the synthesis of fibroblasts at the level of the papilla of the hair follicles of said annexes.
• it is an increase in the number of fibroblasts of the papilla of at least 10%, preferentially of at least 20%, more preferentially of at least 25%, in presence of the hydrolyzate according to the invention, in comparison with the number of fibroblasts measured without hydrolyzate.
• this is an increase in the number of fibroblasts measured at the level of the papilla of the hair follicles.
• this increase is measured in the presence of the hydrolyzate prepared according to Example 1 a), under the conditions described in Example 4 (Table 10).
• the term “increase the growth of the cutaneous appendages” is understood to mean an elongation of the keratin fibers of at least 5%, advantageously of at least 10% in the presence of the hydrolyzate according to the invention, advantageously in the presence of an agent which sensitizes said fibers and slows down their elongation, in comparison with the elongation of control keratin fibers sensitized with said agent but without hydrolyzate.
• the sensitizing agent is capsaicin.
• the meal hydrolyzate of /7. rhamnoides is that prepared as described in Example 1 a), under the conditions set out in Example 5.
• reducing the fall of the cutaneous appendages also means increasing the quantity of DNA in the fibroblasts of the papilla of the hair follicles, when they are sensitized with a dedicated agent.
• it is an increase of at least 25%, advantageously of at least 50% and very advantageously of at least 60%, of the quantity of DNA measured at the level of fibroblasts sensitized by capsaicin and in the presence of the hydrolyzate according to the invention, in comparison of the amount of DNA measured in the same fibroblasts sensitized with capsaicin and without hydrolyzate.
• "reducing the fall of the cutaneous appendages” means increasing the number of fibroblasts of the papilla sensitized by capsaicin by at least 20%, preferentially by at least 30%, still preferentially by at least least 50%, in the presence of capsaicin and the hydrolyzate according to the invention, in comparison with the number of fibroblasts sensitized by capsaicin and without hydrolyzate.
• “reducing the fall of skin appendages” means increasing the quantity of ATP in the fibroblasts of the papilla of the hair follicles, preferentially when they are sensitized with capsaicin. In an advantageous embodiment, it is an increase in the quantity of ATP measured at the level of the fibroblasts of the hair papilla, advantageously subjected to sensitization with capsaicin, in the presence of the hydrolyzate according to invention, by at least 100%, preferably by at least 130% measured at the level of fibroblasts sensitized by capsaicin and in the presence of the hydrolyzate according to the invention, in comparison with the quantity of ATP measured at the level of the same fibroblasts sensitized by capsaicin without hydrolyzate.
• it is an increase in the quantity of ATP measured at the level of the papilla of the hair follicles. Again advantageously, this increase is measured in the presence of the hydrolyzate prepared according to Example 1a), under the conditions described in Example 4 (Table 9).
• the properties of increasing the growth of skin appendages, in particular hair, as well as increasing the biomechanical and/or surface and/or texture properties of the hydrolyzate according to the invention make it an active ingredient on the skin. improvement of the volume, color, shine and radiance of the cutaneous appendages, and in particular of the hair.
• the effectiveness of the hydrolyzate according to the invention on the biomechanical properties of the cutaneous appendages, in particular the hair, can moreover be demonstrated by various tests including tension force tests (Diastron), fatigue tests, or repeated styling tests of the hair to assess breakage. It is also possible to quantify hair fibers with forks. It will also be possible to evaluate these biomechanical properties by measuring the styling force required on dry or wet hair.
• the distribution of the hydrolyzate is studied in the hair by various imaging and microscopy techniques. Still advantageously, Fourier transform infrared spectrometry (FTIR) can be used.
• FTIR Fourier transform infrared spectrometry
• the hair is studied by IRTF after having been cut transversely, after application of the hydrolyzate according to the invention on hair damaged by an oxidizing agent, in comparison with the same hair damaged by the same oxidizing agent without application of the hydrolyzate, or undamaged hair.
• the vibrational profiles of the hydrolyzate are then compared to the vibrational profiles of the cut to evaluate the distribution of the product in the hair.
• the oxidizing agent is hydrogen peroxide.
• repairing damaged skin appendages also means a repairing effect of the hydrolyzate according to the invention on skin appendages damaged by nutritional deficiencies, pollutants chosen from fine particles called PM2.5 and PM10, metals, such as for example copper or iron, heavy metals, climatic and/or environmental conditions such as wind, rain, sudden variations in temperature and humidity, cold, heat, UV rays, salt salt, chlorine from swimming pools and other physical agents or chemical agents, including hydrogen peroxide, in particular present in certain shampoos, cosmetic make-up products, hair coloring, bleaching, perm products, varnishes, solvents and household products, mechanical aggressions such as friction with brushing, heat with hair dryers and straighteners for example, but also intrinsic aging and t/or chrono- induced.
• pollutants chosen from fine particles called PM2.5 and PM10
• metals such as for example copper or iron, heavy metals, climatic and/or environmental conditions such as wind, rain, sudden variations in temperature and humidity, cold, heat, UV rays, salt salt, chlorine from swimming pools and other physical agents or
• the term “repairing the skin appendages” means at least partially improving the structure and/or the visual properties and/or the biomechanical properties of the skin appendages, preferably the hair. This repair is preferentially evaluated when the skin appendages are exposed to environmental, chemical, biological and/or mechanical attacks.
• Environmental attacks include in particular smoke, pollution, temperature, in particular hot and cold, and their sudden variations, water content, in particular humidity or dryness, solar irradiation, in particular visible spectra, UV and/or gamma rays, rain, wind, dust, and sea salt.
• Chemical attacks include aggressive household products, chlorine from swimming pools, aggressive cosmetic products such as coloring and bleaching, varnishes and/or solvents, solvents, make-up products.
• Chemical attacks on the hair include in particular aggressive shampoos and hair care and/or treatment, in particular for styling, shaping such as straightening and/or permanent waves and/or for coloring and/or bleaching.
• Mechanical attacks include in particular friction such as brushing and/or friction on fabrics (ears, clothing) and/or particles such as dust and/or sand, heat with hair dryers and straighteners, and/or styling with in particular exposure to tensile, stretching and/or twisting forces.
• the hydrolyzate according to the invention is also effective as an anti-ageing ingredient for the appendages of the skin, advantageously of the hair, and/or of the skin, advantageously of the scalp, and/or of the mucous membranes, by reducing the negative effects of ageing.
• the repairing effect can be evaluated according to existing techniques in the field.
• Conventional methods for measuring a repair effect make it possible to measure the ability of the product evaluated to restore a visual, structural and/or functional state of a damaged skin appendix, preferably damaged hair comparable to the state of an appendix undamaged skin, preferably undamaged hair. They are implemented on damaged skin appendages, preferably hair, and the repair effect is measured by comparison with undamaged skin appendages, preferably hair.
• the repairing effect is a repairing effect on the skin appendages damaged in vitro by an oxidizing agent, which induces a denaturation of the proteins of the appendages.
• this is a repairing effect of the hydrolyzate on the hair and preferentially again the oxidizing agent is hydrogen peroxide.
• this protein denaturation is evaluated by measuring the protein denaturation temperature (°C) p differential calorimetry (Wortmann and Deutz, Appl. Polym. Sci., 48, 137-150 (1993)) using a differential enthalpy analyzer (DSC Q100, TA Instruments), under the conditions described in example 6.
• repair of the damaged appendages is at least 20%, preferably at least 30% compared to so-called healthy appendages, that is to say not subject to the oxidative stress induced by hydrogen peroxide.
• this involves measuring the repair index in the presence of the hydrolyzate as prepared according to Example 1a), under the conditions described in Example 6.
• the hydrolyzate according to the invention is a hydrolyzate obtained by enzymatic or chemical hydrolysis of the coproduct of the supercritical CO 2 extraction of the seeds of /7. rhamnoides, ie the co-product of the oil, or the co-product obtained after pressing the said seeds.
• the seed corresponds to the berry (or fruit) of /7. rhamnoides stripped of the fleshy part, otherwise called pericarp.
• Supercritical extraction with carbon dioxide is a technique known to those skilled in the art which makes it possible to isolate the oily fraction of the compound to be extracted in order to use it for various applications.
• the residue of this extraction is called “co-product” within the meaning of the present invention and contains all the compounds not extracted by said technique.
• co-product we therefore mean the residue obtained after extraction of the oil, also called cake.
• cake will be used in the remainder of the description.
• it is therefore the delipidated fraction of the /7 seed.
• rhamnoides Preferably, it is the enzymatic or chemical hydrolyzate of the coproduct of supercritical CO 2 extraction of the seeds of /7. rhamnoides, again preferentially from its enzymatic hydrolyzate.
• the co-product does not contain any oil.
• the enzymatic hydrolysis can be carried out in the presence of any protease known to those skilled in the art, and advantageously in the presence of an enzyme of animal origin chosen from pepsin, enzymes of pancreatic origin such as trypsin or chymotrypsin , and preferably trypsin, of plant origin chosen from papain, bromelain, ficin, actinidin, preferably papain, or even of bacterial origin chosen from the enzyme originating from the strain Bacillus licheniformis marketed under the name of Alcalase® or of the B. subtilis strain, preferably Alcalase®.
• the enzyme used is Alcalase®.
• the hydrolysis can be carried out at a pH between 3 and 9 depending on the optimum pH of the enzyme, and advantageously at a pH between 4 and 8.5, very advantageously has a pH of 8.5.
• the hydrolysis can be carried out at a temperature of 40° C. to 65° C., advantageously from 50 to 60° C. and very advantageously at 55° C. It is carried out during a period of 1 hour to 3 hours and preferably during a period of 2 hours.
• the enzyme used is then inactivated by heating, advantageously at a temperature of 80° C. to 100° C. and very advantageously at a temperature of 90° C., for a period of 5 minutes to 30 minutes, preferably for a period of 10 minutes. .
• the inactivation of the enzyme takes place at pH between 5 and 8, preferably at pH 6.5.
• the hydrolyzate obtained is then centrifuged and then purified by successive filtrations to a porosity of 0.22 ⁇ m.
• the proteins are previously extracted from the meal.
• they are extracted at a pH of between 7.5 and 10, advantageously at a pH of between 8 and 9, very advantageously at a pH of 9.0, for a period of 30 minutes to 2 hours, preferably for a period of 1 hour.
• the amount by weight of cake used for the extraction of the proteins and their hydrolysis is between 5% and 20%, advantageously between 5% and 15%, even more advantageously it is 10%, by weight relative to the total weight of the solvent and meal.
• the solvent used for the protein extraction is chosen from water, coconut water as solvent as described in application FR3061416, or else a solvent comprising at least 50% by weight relative to the total weight of the solvent at least one C 6 -Ci 6 dialkyl carbonate as described in application FR3069450, among which a C7-C10 dialkyl carbonate, advantageously C 8 , for example dioctyl carbonate or diethylhexyl carbonate.
• the solvent used is water as sole solvent.
• Said protein extraction can be carried out at a temperature of 4°C to 300°C, advantageously from 4°C to 100°C, further advantageously from 15°C to 80°C, very advantageously from 15°C to 30°C, including the room temperature, i.e. at a temperature of 20°C.
• the protein extraction is carried out at room temperature.
• the extraction is carried out under subcritical conditions.
• extraction in “subcritical conditions” is meant an extraction in the presence of water, under conditions of temperature above 100° C. and pressure below 22.1 MPa (221 bar), such that the water remains at the liquid state but has a lower viscosity and surface tension than water at room temperature, increasing its dielectric constant.
• the extraction pressure will be between 10 MPa (100 bars) and 25 MPa (250 bars), preferably between 15 and 22.1 MPa (150 and 221 bars).
• the extraction is carried out in water at a temperature ranging from 100° C. to 300° C., advantageously from 120° C. to 250° C., again advantageously between 140° C. and 200° C.
• the extraction can be carried out at a single given temperature or at successive increasing temperatures.
• the extraction will be carried out at a single temperature of 160°C.
• it will be conducted according to a gradient of three increasing temperatures between 100°C and 200°C, such as 120°C, 140°C then 160°C or 110°C, 130°C then 150°C , or eo ⁇ 120°C, 145°C then 170°C.
• the hydrolyzate is obtained by enzymatic digestion as follows: the proteins are extracted for a period of one hour at room temperature, at pH 12, from a quantity of 10 % by weight of cake relative to the total weight of cake and water as solvent. The proteins thus extracted are subjected to hydrolysis for a period of 2 hours at a temperature of 55°C and at pH 8.5, in the presence of a concentration by volume of 5% of Alcalase® relative to the total volume. Alcalase® and proteins. The enzyme is inactivated by heating for a period of 20 minutes at a temperature of 90°C and at pH 6.5. The mixture is then cooled, centrifuged, filtered (0.22 ⁇ m), under the conditions as described in Example 1 a).
• the cake proteins are extracted for a period of one hour at ambient temperature, that is to say at a temperature of 20°C, at pH 8.5, from a quantity of 10% in cake weight relative to the total weight of cake and water as solvent.
• the proteins thus extracted are subjected to hydrolysis for a period of 2 hours at a temperature of 55°C and at pH 8.5, in the presence of a concentration by volume of 5% of Alcalase® relative to the total volume of Alcalase. ® and protein.
• the enzyme is inactivated by heating for a period of 20 minutes at a temperature of 90°C and at pH 6.5.
• the mixture is then cooled, centrifuged, filtered (0.22 ⁇ m) under the conditions described in Example 1 b).
• the cake proteins are extracted for a period of one hour at room temperature, that is to say at a temperature of 20 ° C, at pH 12, from a quantity of 10% by weight of oilcake relative to the total weight of oilcake and water as solvent.
• the proteins thus extracted are subjected to hydrolysis for a period of 2 hours at a temperature of 55° C. and at pH 8.5, in the presence of a concentration by volume of 5% of papain relative to the total volume of papain and proteins. .
• the papain is inactivated by heating for a period of 20 minutes at a temperature of 90°C and at pH 6.5.
• the mixture is then cooled, centrifuged, filtered (0.22 ⁇ m) and under the conditions as described in Example 1 c).
• the hydrolyzate according to the invention therefore comprises a dry matter content of 1% to 20% by weight, advantageously from 2 to 10% by weight, including 5%, a total protein content of 15 g/L to 35 g/L of hydrolyzate, advantageously 18.8 g/L of hydrolyzate, as well as a percentage of peptides with a molecular weight of 5kDalton (Da) to 30kDa comprised between 15 and 40%, advantageously 18.25%, a percentage of peptides with a molecular weight of less than 5 KDa comprised between 40% and 85%, advantageously 72.6% (Example 2).
• the hydrolyzate comprises a dry matter content of at least 3% by weight, in particular of at least 3.5% by weight, more particularly of 3.44% by weight, very advantageously of 3.84% in weight.
• the hydrolyzate comprises a dry matter content of 5% by weight.
• the hydrolyzate comprises a percentage of peptides with a molecular weight of 5 kDa to 30 kDa of 18.25%, and a percentage of peptides with a molecular weight of less than 5 kDa of 72.6%.
• the hydrolyzate according to the invention does not contain gallic acid, nor any of the polymers hydrolyzable to gallic acid, nor hexahydroxydiphenic acid, nor any of the polymers hydrolyzable to hexahydroxydiphenic acid, nor any ellagic acid or any of the polymers hydrolysable to ellagic acid, or gallotannins, or ellagitannins.
• the hydrolyzate also does not contain any of the derivatives of the compounds mentioned or any of their salts, in particular as described in patent application FR031455.
• the hydrolyzate according to the invention does not contain L-quebrachitol, nor other methyl inositols and/or inositols as described in WO2009/125071.
• the hydrolyzate according to the invention does not contain myricetin, quercetin, Kampfaerol or isorhamnetin.
• the hydrolyzate in particular as prepared in Examples 1 a) to 1 c), is thus in liquid form.
• the hydrolyzate can then be dried, for example by lyophilization or by atomization in the presence of maltodextrins.
• the hydrolyzate then comes in the form of a powder.
• the hydrolyzate according to the invention in particular obtained under the conditions described in examples 1 a) to 1 c), is atomized in the presence of a concentration by weight of maltodextrins of between 20% and 90%, preferably between 40 and 80%, more preferably 70 to 80% relative to the total weight of the powder obtained.
• the hydrolyzate according to the invention can be used alone or incorporated into a cosmetic composition.
• an aqueous solution containing glycerin advantageously present at a concentration of 60% to 90%, again advantageously of 70% to 85%, very advantageously at a concentration of 80% by weight relative to the total weight of the aqueous solution comprising the hydrolyzate.
• the hydrolyzate will be dissolved and/or diluted in a particularly polar solvent, such as water, an alcohol, a polyol, a glycol, such as pentylene glycol and/or butylene glycol and/or propylene glycol and/or hexylene glycol and/or caprylyl glycol, or one of their mixtures, preferably a hydroglycolic mixture, again preferably containing a glycol chosen from hexylene glycol, propylene glycol, caprylyl glycol and any mixture thereof.
• a particularly polar solvent such as water, an alcohol, a polyol, a glycol, such as pentylene glycol and/or butylene glycol and/or propylene glycol and/or hexylene glycol and/or caprylyl glycol, or one of their mixtures, preferably a hydroglycolic mixture, again preferably containing a glycol chosen from hexylene glycol, propylene glycol, capryly
• the hydrolyzate obtained is diluted and/or soluble in an aqueous solution containing hexylene glycol, in particular containing between 0.1 and 10% by weight of hexylene glycol, preferably between 0.5 and 5% by weight of hexylene glycol, relative to the total weight of the cosmetic ingredient.
• the hydrolyzate obtained is diluted and/or soluble in an aqueous solution containing caprylyl glycol, in particular containing between 0.01 and 5% by weight of caprylyl glycol, preferentially between 0.1 and 1% by weight of caprylyl glycol, relative to the total weight of the aqueous solution comprising the hydrolyzate.
• the solution in which is solubilizes the hydrolyzate according to the invention comprises propylene glycol and caprylyl glycol.
• the aqueous solution in which the hydrolyzate according to the invention is dissolved comprises xanthan gum, in particular between 0.01 and 5% by weight of xanthan gum relative to the total weight of the aqueous solution, more particularly between 0.1 and 1% by weight of xanthan gum relative to the total weight of the aqueous solution comprising the hydrolyzate.
• the solution in which the hydrolyzate according to the invention is dissolved comprises hexylene glycol, caprylyl glycol and xanthan gum.
• the extract is dissolved in a solution comprising a mixture of sodium benzoate and glucunolactone marketed under the name GeogardTM.
• the hydrolyzate can be incorporated into a cosmetic composition comprising at least one cosmetically acceptable excipient.
• cosmetically acceptable excipient is understood to mean a topically acceptable compound and/or solvent, that is to say not inducing an inflammatory and allergic response on contact with the skin, in particular the scalp, non-toxic, non-stable, or their equivalents, undue.
• the term “cosmetic composition” means a non-therapeutic composition, that is to say a composition intended for the prevention and/or care of the skin, in particular of the scalp, and/or of the so-called “normal” by a dermatologist, that is to say not pathological.
• “normal” skin or scalp or cutaneous appendix is understood to mean a healthy skin or scalp or cutaneous appendix as defined previously.
• the hydrolyzate according to the invention is present in the cosmetic composition in a content of between 1x10' 4 % to 10% by weight, preferentially from 1x10' 4 % to 5% by weight, again advantageously from 1 ⁇ 10 3 % to 3% by weight, more preferably from 0.001% and 0.1% by weight, relative to the total weight of the composition.
• the composition can therefore be used to increase the growth of skin appendages and/or reduce their loss, advantageously of hair; and/or to maintain and/or increase the biomechanical properties and/or the surface and/or texture properties of the skin appendages, advantageously of the hair; and/or to repair damaged skin appendages, advantageously the hair.
• the cosmetic composition according to the invention may be in the galenic forms conventionally used for topical application to the skin or the scalp and/or the skin appendages, preferably the scalp and/or the skin appendages, such as the forms liquids or solids or even in the form of liquid under pressure.
• aqueous or oily solution a cream or an aqueous gel or an oily gel, in particular in a jar or in a tube, in particular a shower gel, a shampoo, a conditioner, a milk, an oil, an emulsion, a hydrogel, a microemulsion or a nano-emulsion, in particular oil-in-water or water-in-oil or multiple or silicone-based, a serum, a lotion, in particular in a glass, plastic or dispenser or aerosol or spray bottle, an ampoule, a liquid soap, a paste, a dermatological bar, an ointment, a foam, a mask, a lacquer, a patch, a varnish, an anhydrous product, preferably liquid, pasty or solid, for example in the form of a stick, in particular in a stick or in powders.
• the cosmetic composition is chosen from the group consisting of a serum, a lotion, a cream, a shampoo, a conditioner, an oil, a milk, an ointment, a paste, a mousse, an emulsion, a hydrogel , a shower gel, a mask, a lacquer, a spray, a wax, a mascara, a make-up pencil, a verm, advantageously in the form of a shampoo, conditioner or lotion.
• the hydrolyzate is suitable for the formulation of a so-called neutral and gentle composition for respecting the keratin fibre, in particular the hair fibre, and the skin, in particular the scalp.
• the hydrolyzate is also suitable for use in cationic formulations with surfactants.
• compositions according to the invention may contain any suitable solvent and/or any suitable vehicle and/or any suitable excipient, optionally in combination with other compounds of interest. They may in particular contain a cosmetically acceptable excipient chosen from surfactants, preservatives, buffering agents, swelling agents, chelating agents, biocidal agents, denaturants, opacifying agents, pH adjusters, reducing agents, stabilizers, emulsifiers, thickeners, gelling agents, film-forming polymers, solvents, fillers, bactericides, odor absorbers, matting agents, conditioning agents, texture agents, shine agents, pigments, dyes, perfumes and chemical or mineral sunscreens, trace elements, essential oils. These combinations are also covered by the present invention.
• a cosmetically acceptable excipient chosen from surfactants, preservatives, buffering agents, swelling agents, chelating agents, biocidal agents, denaturants, opacifying agents, pH adjusters, reducing agents, stabilizers, emulsifiers, thickeners, gelling agents
• the cosmetic composition may contain other cosmetic agents possessing properties identical to the hydrolyzate according to the invention and inducing a synergistic effect or not with said hydrolyzate, or contain cosmetic agents with complementary effects.
• an anti-hair loss active ingredient mention will be made of the combination of sulfopeptides, amino acids, aminosaccharides, vitamin B group, zinc and extract of Panax ginseng and Artium majus marketed under the name TrichogenTM LS 8960 by the applicant or a capillary protective agent such as an extract of Litchi chinensis pericarp marketed under the name LitezermTM by the applicant, a soothing and anti-itch active ingredient such as rapeseed phytosterols marketed under the name of PhytosootheTM LS9766 by the applicant.
• compositions such as an extract of Cassia alata leaves marketed under the name DN-AgeTM as an antioxidant active ingredient for hair care in particular, a combination of a extract of Salvia miltiorhizza and niacinamide marketed under the name ColIRepairTM as a deglycating agent, or active ingredients promoting the firmness of the skin and therefore of the scalp, such as a synthetic tetrapeptide marketed under the name DermicanTM, a extract of Hibiscus abelmoschus marketed under the name LinefactorTM, a purified pea extract marketed under the name ProteasylTM, an extract of Manilkara multinervis marketed under the name ElestanTM, an extract of Khaya senegalensis marketed under the name CollaliftTM18, an extract of Argan pulp marketed under the name ArgassentialTM by the plaintiff, an extract of Schizandra chinensis marketed under the name SqisandrylTM, an extract of
• the hydrolyzate of the invention can also be combined with an extract from the seeds of the Nephelium lappaceum plant, marketed under the name RambuvitalTM by the applicant for its protective properties for the hair, in particular against pollution.
• a third object of the invention relates to a cosmetic, non-therapeutic care process, comprising the topical application of the hydrolyzate according to the invention or of a cosmetic composition comprising, to increase the growth of skin appendages and/or decrease their loss, advantageously hair; to maintain and/or increase the biomechanical properties and/or the surface and/or texture properties of the skin appendages, advantageously of the hair; and/or to repair damaged skin appendages, advantageously the hair.
• the cosmetic care process consists of the topical application of the hydrolyzate according to the invention or of the cosmetic composition comprising it on all or part of the skin of the body and/ or face chosen from the scalp, legs, thighs, arms, stomach, Vietnameselleté, neck, all or part of the face, forehead, chin, lips, lip contour, eye contour eyes, the so-called “T” area of the face, and advantageously the scalp, and/or on all or part of the skin appendages, advantageously on the nails, hair, body hair, in particular beard hair, eyelashes and/or or eyebrows, even more advantageously on the hair, more preferentially the hair.
• the cosmetic care process therefore makes it possible to improve the color and/or the shine and/or the radiance and/or the volume of the skin appendages, advantageously of the hair.
• Another object also relates to a method of cosmetic treatment for increasing the growth of skin appendages and/or reducing their loss, advantageously of hair; and/or to maintain and/or increase the biomechanical properties and/or the surface and/or texture properties of the skin appendages, advantageously of the hair; and/or to repair damaged skin appendages, advantageously the hair, and comprising the steps of:
• Topical application of the hydrolyzate according to the invention or of the composition comprising it in this case at a content of between 1x10' 4 % to 10% by weight, preferably from 1x10' 4 % to 5% by weight, again advantageously from 1 ⁇ 10 3 % to 3% by weight, more preferably from 0.001% and 0.1% by weight, relative to the total weight of the composition.
• a final object concerns a meal hydrolyzate of /7. rhamnoides for its use, alone or in a dermatological or pharmaceutical composition, which comprises at least one dermatologically or pharmaceutically acceptable excipient, in the treatment of alopecia and/or baldness.
• the hydrolyzate is as described in the present invention and is present in the dermatological or pharmaceutical composition at a content of between 1x10' 4 % to 10% by weight, preferably 1x10' 4 % to 5% by weight, again advantageously from 1 ⁇ 10 3 % to 3% by weight, more preferably from 0.001% and 0.1% by weight, relative to the total weight of the composition.
• the temperature is expressed in degrees Celsius and the pressure is the atmospheric pressure.
• Example 1 different methods of preparation of the meal hydrolyzate
• the proteins thus extracted were subjected to hydrolysis for a period of 2 hours at a temperature of 55°C and at pH 8.5, with a concentration by volume of 5% of alcalase in liquid form relative to the total volume of alkalase and protein.
• the enzyme was inactivated by heating for a period of 20 minutes at a temperature of 90°C and at pH 6.5. The mixture was then cooled, centrifuged, filtered (0.22 ⁇ m).
• the proteins thus extracted were subjected to hydrolysis for a period of 2 hours at a temperature of 55°C and at pH 8.5, with a concentration by volume of 5% of alcalase in liquid form relative to the total volume of alkalase and protein.
• the enzyme was inactivated by heating for a period of 20 minutes at a temperature of 90°C and at pH 6.5. The mixture was then cooled, centrifuged, filtered (0.22 ⁇ m).
• the proteins thus extracted were subjected to hydrolysis for a period of 2 hours at a temperature of 55°C and at pH 8.5, with a concentration by volume of 5% of papain in liquid form relative to the total volume of papain and of proteins.
• the enzyme was inactivated by heating for a period of 20 minutes at a temperature of 90° C. and at pH 6.5. The mixture was then cooled, centrifuged, filtered (0.22 ⁇ m).
• Example 2 Total protein content of the hydrolyzate according to the invention and analysis of the peptide molecular weight profile Example 2a) Assay of total proteins:
• the protein content of the raw materials and extracts was estimated by measuring total nitrogen (Kjeldahl method) and multiplying the value obtained by a factor of 6.25 (N x 6.25).
• Example 1 a is between 18 and 32 g/L of protein (Table 1). Total proteins represent between 37 and 65% of the dry matter.
• a reagent comprising albumin at 1.5%, iron at 2 mM, EDTA at 5 mM and hydrogen peroxide H 2 O 2 at 25 mM was placed in the presence or not of the hydrolyzate of /7. rhamnoides.
• Albumin oxidizes in the presence of H 2 O 2 .
• the oxidation reaction is catalyzed by iron.
• a control of the catalysis of the oxidation reaction was carried out in the absence of iron. The mixture was incubated at 37°C for 1 day.
• the amount of tryptophan, dityrosine, pentosidine and glycation products were measured by fluorescence (excitation/emission wavelengths: 280 nm / 340 nm for tryptophan; 315 nm / 410 nm for dityrosine 335 nm / 385 nm for pentosidine 370 nm /
• the addition of the hydrolyzate according to the invention reduced the degradation of tryptophan by at least 30% following the oxidation of albumin, showing its ability to reduce the oxidation of proteins and therefore to maintain and /or increase the mechanical properties of the skin appendages, in particular the hair.
• the addition of the hydrolyzate according to the invention reduced the formation of dityrosine by at least 35% following the oxidation of albumin, showing its ability to reduce the oxidation of proteins and therefore to maintain and/ or increase the mechanical properties of the cutaneous appendages, in particular of the hair.
• Control conditions were carried out by the addition of growth factor cocktail at 0.05% v/v (Ethanol EtOH control) and the addition of capsaicin (10 ⁇ m) as a cell sensitizing agent (Control Capsaicin) in the basal culture medium.
• the aggregates were incubated at a temperature of 37° C. under a controlled atmosphere (5% CQ and relative humidity of 95%).
• the aggregates were rinsed in a buffered saline solution (PBS) and the cells were separated by incubation in a mixture of proteases (Collagenase A, Trypsin) with EDTA.
• PBS buffered saline solution
• Results they are collated in Tables 8 (effects of the hydrolyzate of /7. rhamnoides on the quantity of DNA of the fibroblasts of the papilla cultured in aggregates) 9 (effects of the hydrolyzate of /7. rhamnoides on production of ATP by papilla fibroblasts cultured in aggregates), 10 (effects of /7. rhamnoides hydrolyzate on the number of papilla fibroblasts cultured in aggregates, their granularity and their autofluorescence measured by flow cytometry flow).
• the number of cells measured in the presence of the hydrolyzate is also greater than the control not sensitized to capsaicin, showing an effect of increasing the number of fibroblasts and therefore an effect on hair growth.
• Locks of dark brown hair of the Caucasian type were calibrated (1 g; 12 cm) and prepared for the study.
• Healthy (unbleached) locks of hair were kept as a control.
• the locks of hair were immersed for 24 hours in distilled water (as a control) or in an aqueous solution containing 1% hydrolyzate of /7. rhamnoides.
• the two solutions were previously buffered at pH 5.5.
• the locks were rinsed and then dried for 1 hour at approximately 60° C. under a flow of air.
• the denaturation temperature of human proteins was determined by differential calorimetry (Wortmann et al. 1993) with a heating rate of 2 K/min and a differential enthalpy analyzer (DSC Q100, TA Instruments).
• Example 7 Examples of compositions comprising the hydrolyzate according to the invention Example 7a): shampoo
• the shampoo is prepared by the usual methods in the field well known to those skilled in the art, by mixing the 4 phases and adjusting the composition to a pH of 5.2 and to a viscosity of 2200 mPas (measured with a Brookfield apparatus (RVT; 23°C, qoindle 5; 50 revolutions per min).
• Example 7b hydroalcoholic solution for scalp
• the hydroalcoholic solution is prepared by the usual methods in the field well known to those skilled in the art, by mixing the 3 phases and adjusting the composition to a pH of 6.2.
• the mask is prepared by the usual methods well known to those skilled in the art, by mixing the 4 phases and adjusting the composition to a pH of 4.1 and a viscosity of 26,000 mPas (measured with a Brookfield apparatus (RVT 23°C, spindle 5; 50 rpm).

Landscapes

• Health & Medical Sciences (AREA)
• Life Sciences & Earth Sciences (AREA)
• Veterinary Medicine (AREA)
• Public Health (AREA)
• General Health & Medical Sciences (AREA)
• Animal Behavior & Ethology (AREA)
• Natural Medicines & Medicinal Plants (AREA)
• Dermatology (AREA)
• Epidemiology (AREA)
• Biotechnology (AREA)
• Botany (AREA)
• Mycology (AREA)
• Engineering & Computer Science (AREA)
• Microbiology (AREA)
• Birds (AREA)
• Alternative & Traditional Medicine (AREA)
• Medical Informatics (AREA)
• Medicinal Chemistry (AREA)
• Chemical & Material Sciences (AREA)
• Pharmacology & Pharmacy (AREA)
• Gerontology & Geriatric Medicine (AREA)
• Cosmetics (AREA)
• Medicines Containing Plant Substances (AREA)
• Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
• Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Priority Applications (6)

Applications Claiming Priority (2)

Publications (1)

Family

ID=74669059

Family Applications (1)

Country Status (8)

Families Citing this family (3)

Citations (12)

Family Cites Families (3)

• 2020
  • 2020-12-15 FR FR2013229A patent/FR3117372B1/fr active Active
• 2021
  • 2021-12-13 JP JP2023535825A patent/JP7844477B2/ja active Active
  • 2021-12-13 US US18/266,822 patent/US20240050359A1/en active Pending
  • 2021-12-13 EP EP21848172.9A patent/EP4262741B1/fr active Active
  • 2021-12-13 KR KR1020237019928A patent/KR20230115996A/ko active Pending
  • 2021-12-13 ES ES21848172T patent/ES3040119T3/es active Active
  • 2021-12-13 CN CN202180083875.0A patent/CN116710062A/zh active Pending
  • 2021-12-13 WO PCT/FR2021/052285 patent/WO2022129750A1/fr not_active Ceased

Patent Citations (12)

Non-Patent Citations (4)

Also Published As

Similar Documents

Legal Events